Uploaded May 2026 | Updated September 2026, 1 week ago

---

Welcome to the official introduction to Insilico Medicine. We are a clinical-stage end-to-end artificial intelligence (AI) drug discovery company connecting biology, chemistry, and clinical trials analysis.

In this video, we provide a deep dive into our mission, our proprietary Pharma.AI platform, and a major milestone for our lead program. By leveraging generative AI, we aren’t just speeding up the process—we’re discovering novel targets and molecules for diseases with high unmet needs.